PDF download SPERA PHARMA, Inc. (headquarters: Osaka; President and Representative Director: Keitaro Iwaki; hereinafter “SPERA PHARMA”), today announced a strategic alliance with Mycenax Biotech Inc. (headq...

READ MORE